Literature DB >> 16945540

QSAR study of antiplatelet agents.

Alan R Katritzky1, Liliana M Pacureanu, Svetoslav Slavov, Dimitar A Dobchev, Mati Karelson.   

Abstract

A QSAR methodology that involves multilinear (Hansch-type) and nonlinear (ANN backpropagation) approaches was developed to correlate the antiplatelet activity of 60 benzoxazinone derivatives against factor Xa. The statistical characteristics provided by multilinear model (R2 = 0.821) indicated satisfactory stability and predictive ability, while the ANN predictive ability is somewhat superior (R2 = 0.909). The multilinear model provided insight into the main factors that modulate the inhibitory activity of the investigated compounds.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16945540     DOI: 10.1016/j.bmc.2006.07.022

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  3 in total

1.  QSAR study on maximal inhibition (Imax) of quaternary ammonium antagonists for S-(-)-nicotine-evoked dopamine release from dopaminergic nerve terminals in rat striatum.

Authors:  Fang Zheng; Matthew J McConnell; Chang-Guo Zhan; Linda P Dwoskin; Peter A Crooks
Journal:  Bioorg Med Chem       Date:  2009-05-08       Impact factor: 3.641

2.  Pharmacophore Identification and QSAR Studies on Substituted Benzoxazinone as Antiplatelet Agents: kNN-MFA Approach.

Authors:  Prafulla B Choudhari; Manish S Bhatia; Swapnil D Jadhav
Journal:  Sci Pharm       Date:  2012-02-26

3.  Hyaluronidase Inhibitory Activity of Pentacylic Triterpenoids from Prismatomeris tetrandra (Roxb.) K. Schum: Isolation, Synthesis and QSAR Study.

Authors:  Nor Hayati Abdullah; Noel Francis Thomas; Yasodha Sivasothy; Vannajan Sanghiran Lee; Sook Yee Liew; Ibrahim Ali Noorbatcha; Khalijah Awang
Journal:  Int J Mol Sci       Date:  2016-02-14       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.